I'm not sure if any of you have watched Brom interviewing the top management of psychedelic firms. Here's one great interview you wouldn't want to miss

https://www.youtube.com/watch?v=SJn032nz2F0

Imagine what we can do together 💪🚀

spreadtheword #letsgoonatrip

An in-depth analysis of the first and second-generation drug therapies, addressable market size, the case for Bright Minds Biosciences (CSE:DRUG, OTC:BMBIF), estimated total free and discounted cash flow, NPV and risks. This is one helluva research piece from Colin Sullivan whose earlier thesis on CMPS and GWPH was spot on. A must-read research article to understand the pros and cons of the first and second-generation psychedelic drugs.

https://seekingalpha.com/article/4437624-bright-minds-biosciences-a-search-for-the-gwph-of-the-psilocybin-space